Warning letter
Imperial Drug & Spice Corp: warning letter of Jan 16, 2002
FDA warning letter UCM144707 · New Jersey District Office
Key facts
| Reference number | UCM144707 |
|---|---|
| Company | Imperial Drug & Spice Corp |
| Subject | CGMP for Finished Pharmaceuticals/OTC Drug Manufacturing/Adulterated |
| Issue date | Jan 16, 2002 |
| Posted date | Jan 16, 2002 |
| Issuing office | New Jersey District Office |
| Product type | Drugs |
| Country | 3 |
| Inspection city | West New York |
| Inspection ZIP | 07093-1208 |
| Inspection start date | Nov 28, 2001 |
| Letter on fda.gov | web.archive.org |
At a glance
- OAI Linked inspection classification
- Yes Form FDA 483 issued
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: